365 related articles for article (PubMed ID: 18976076)
21. Safety and efficacy of convection-enhanced delivery of gemcitabine or carboplatin in a malignant glioma model in rats.
Degen JW; Walbridge S; Vortmeyer AO; Oldfield EH; Lonser RR
J Neurosurg; 2003 Nov; 99(5):893-8. PubMed ID: 14609170
[TBL] [Abstract][Full Text] [Related]
22. Convection-enhanced delivery of nanodiamond drug delivery platforms for intracranial tumor treatment.
Xi G; Robinson E; Mania-Farnell B; Vanin EF; Shim KW; Takao T; Allender EV; Mayanil CS; Soares MB; Ho D; Tomita T
Nanomedicine; 2014 Feb; 10(2):381-91. PubMed ID: 23916888
[TBL] [Abstract][Full Text] [Related]
23. Liposomal formulations of carboplatin injected by convection-enhanced delivery increases the median survival time of F98 glioma bearing rats.
Shi M; Anantha M; Wehbe M; Bally MB; Fortin D; Roy LO; Charest G; Richer M; Paquette B; Sanche L
J Nanobiotechnology; 2018 Oct; 16(1):77. PubMed ID: 30290821
[TBL] [Abstract][Full Text] [Related]
24. Chloride channel-mediated brain glioma targeting of chlorotoxin-modified doxorubicine-loaded liposomes.
Xiang Y; Liang L; Wang X; Wang J; Zhang X; Zhang Q
J Control Release; 2011 Jun; 152(3):402-10. PubMed ID: 21435361
[TBL] [Abstract][Full Text] [Related]
25. Brain tumor-targeted delivery and therapy by focused ultrasound introduced doxorubicin-loaded cationic liposomes.
Lin Q; Mao KL; Tian FR; Yang JJ; Chen PP; Xu J; Fan ZL; Zhao YP; Li WF; Zheng L; Zhao YZ; Lu CT
Cancer Chemother Pharmacol; 2016 Feb; 77(2):269-80. PubMed ID: 26666650
[TBL] [Abstract][Full Text] [Related]
26. Convection-enhanced delivery of tumor necrosis factor-related apoptosis-inducing ligand with systemic administration of temozolomide prolongs survival in an intracranial glioblastoma xenograft model.
Saito R; Bringas JR; Panner A; Tamas M; Pieper RO; Berger MS; Bankiewicz KS
Cancer Res; 2004 Oct; 64(19):6858-62. PubMed ID: 15466173
[TBL] [Abstract][Full Text] [Related]
27. Liposomal temozolomide drug delivery using convection enhanced delivery.
Nordling-David MM; Yaffe R; Guez D; Meirow H; Last D; Grad E; Salomon S; Sharabi S; Levi-Kalisman Y; Golomb G; Mardor Y
J Control Release; 2017 Sep; 261():138-146. PubMed ID: 28666727
[TBL] [Abstract][Full Text] [Related]
28. Phase I and pharmacokinetic study of a stable, polyethylene-glycolated liposomal doxorubicin in patients with solid tumors: the relation between pharmacokinetic property and toxicity.
Hong RL; Tseng YL
Cancer; 2001 May; 91(9):1826-33. PubMed ID: 11335910
[TBL] [Abstract][Full Text] [Related]
29. Convection-enhanced delivery in the treatment of malignant glioma.
Lopez KA; Waziri AE; Canoll PD; Bruce JN
Neurol Res; 2006 Jul; 28(5):542-8. PubMed ID: 16808887
[TBL] [Abstract][Full Text] [Related]
30. Convection-enhanced Delivery of Therapeutics for Malignant Gliomas.
Saito R; Tominaga T
Neurol Med Chir (Tokyo); 2017 Jan; 57(1):8-16. PubMed ID: 27980285
[TBL] [Abstract][Full Text] [Related]
31. Convection-enhanced delivery of a hydrophilic nitrosourea ameliorates deficits and suppresses tumor growth in experimental spinal cord glioma models.
Ogita S; Endo T; Sugiyama S; Saito R; Inoue T; Sumiyoshi A; Nonaka H; Kawashima R; Sonoda Y; Tominaga T
Acta Neurochir (Wien); 2017 May; 159(5):939-946. PubMed ID: 28247160
[TBL] [Abstract][Full Text] [Related]
32. Convection-enhanced delivery for treatment of brain tumors.
Ferguson SD; Foster K; Yamini B
Expert Rev Anticancer Ther; 2007 Dec; 7(12 Suppl):S79-85. PubMed ID: 18076322
[TBL] [Abstract][Full Text] [Related]
33. Tissue affinity of the infusate affects the distribution volume during convection-enhanced delivery into rodent brains: implications for local drug delivery.
Saito R; Krauze MT; Noble CO; Tamas M; Drummond DC; Kirpotin DB; Berger MS; Park JW; Bankiewicz KS
J Neurosci Methods; 2006 Jun; 154(1-2):225-32. PubMed ID: 16472868
[TBL] [Abstract][Full Text] [Related]
34. Convection enhanced delivery of cisplatin-loaded brain penetrating nanoparticles cures malignant glioma in rats.
Zhang C; Nance EA; Mastorakos P; Chisholm J; Berry S; Eberhart C; Tyler B; Brem H; Suk JS; Hanes J
J Control Release; 2017 Oct; 263():112-119. PubMed ID: 28279797
[TBL] [Abstract][Full Text] [Related]
35. Therapeutic efficacy of targeting chemotherapy using local hyperthermia and thermosensitive liposome: evaluation of drug distribution in a rat glioma model.
Aoki H; Kakinuma K; Morita K; Kato M; Uzuka T; Igor G; Takahashi H; Tanaka R
Int J Hyperthermia; 2004 Sep; 20(6):595-605. PubMed ID: 15370816
[TBL] [Abstract][Full Text] [Related]
36. Distribution of liposomes into brain and rat brain tumor models by convection-enhanced delivery monitored with magnetic resonance imaging.
Saito R; Bringas JR; McKnight TR; Wendland MF; Mamot C; Drummond DC; Kirpotin DB; Park JW; Berger MS; Bankiewicz KS
Cancer Res; 2004 Apr; 64(7):2572-9. PubMed ID: 15059914
[TBL] [Abstract][Full Text] [Related]
37. Future of convection-enhanced delivery in the treatment of brain tumors.
Bidros DS; Liu JK; Vogelbaum MA
Future Oncol; 2010 Jan; 6(1):117-25. PubMed ID: 20021213
[TBL] [Abstract][Full Text] [Related]
38. Convection enhanced delivery of panobinostat (LBH589)-loaded pluronic nano-micelles prolongs survival in the F98 rat glioma model.
Singleton WG; Collins AM; Bienemann AS; Killick-Cole CL; Haynes HR; Asby DJ; Butts CP; Wyatt MJ; Barua NU; Gill SS
Int J Nanomedicine; 2017; 12():1385-1399. PubMed ID: 28260886
[TBL] [Abstract][Full Text] [Related]
39. Direct comparison of two pegylated liposomal doxorubicin formulations: is AUC predictive for toxicity and efficacy?
Cui J; Li C; Guo W; Li Y; Wang C; Zhang L; Zhang L; Hao Y; Wang Y
J Control Release; 2007 Apr; 118(2):204-15. PubMed ID: 17239468
[TBL] [Abstract][Full Text] [Related]
40. The distribution, clearance, and brainstem toxicity of panobinostat administered by convection-enhanced delivery.
Singleton WGB; Bienemann AS; Woolley M; Johnson D; Lewis O; Wyatt MJ; Damment SJP; Boulter LJ; Killick-Cole CL; Asby DJ; Gill SS
J Neurosurg Pediatr; 2018 Sep; 22(3):288-296. PubMed ID: 29856296
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
